Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis

This study has been terminated.
Information provided by (Responsible Party):
Baxalta US Inc. Identifier:
First received: February 20, 2012
Last updated: June 26, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)